arrow_back Back to App

Sickle Cell Awareness Day Support: Better Detection and Treatment Access

This resolution supports designating June 19 as World Sickle Cell Awareness Day to boost public knowledge about the disease. It aims to improve access to screenings, treatments, and preventive care programs, significantly impacting the health and quality of life for affected individuals, especially vulnerable populations.
Key points
Increasing public awareness of sickle cell disease and its complications.
Supporting scientific research, early detection, and new treatment methods.
Striving for equitable access to innovative therapies for all social groups, including within Medicare and Medicaid systems.
Encouraging the creation of support and education programs for patients and their families.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_1304
Sponsor: Rep. Davis, Danny K. [D-IL-7]
Process start date: 2024-06-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of June 19, 2024, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_1304.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-06-18.

What are the main provisions?

Key points include:

  • Increasing public awareness of sickle cell disease and its complications.
  • Supporting scientific research, early detection, and new treatment methods.
  • Striving for equitable access to innovative therapies for all social groups, including within Medicare and Medicaid systems.
  • Encouraging the creation of support and education programs for patients and their families.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Davis, Danny K. [D-IL-7].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health